GANX
Gain Therapeutics Inc
1.80$
-3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -3,612.6% | -4,524.1% | -11,219.3% | -7,494.6% | -10,486.3% | -34,189.7% | – | – | |
| 3.6% | 6.2% | 33.2% | 9.4% | 45.8% | 151.5% | – | – | |
| – | 0.0% | 282.7% | 508.7% | 1,089.5% | 5,906.2% | – | – | |
| -169.6% | -211.8% | -94.3% | 1,114.7% | 941.8% | – | – | – | |
| 1,549.0% | 756.1% | 822.4% | -199.9% | 1,081.2% | 801.4% | – | – | |
| 38.8% | 33.2% | 72.1% | 57.1% | 84.9% | 27.8% | – | – | |
| -38.8% | -33.2% | -72.1% | -57.1% | -10,545.3% | 18,526.0% | – | – | |
| 4,773.5% | 1,787.6% | 2,556.3% | -13.3% | -56.2% | -161.4% | – | – | |
| 4,773.5% | 4,240.8% | 36,310.9% | 25,314.1% | -56.2% | 22,909.3% | – | – | |
| 1,154.3% | -235.3% | 24,897.3% | 17,823.5% | -21,104.8% | 8,130.7% | – | – | |
| -3,651.3% | -4,557.4% | -11,291.4% | -7,551.7% | -10,571.2% | -34,217.5% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.